Largest health care companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
UnitedHealth Group leads the 170 health care companies ranked by net assets, at PLN 402.9B, ahead of Pfizer (PLN 348.1B) and Johnson & Johnson (PLN 328.2B). Figures as of 19 Nov 2026, 04:24 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupPLN 402.9B
- Median
- PLN 10.3B
- Combined market value
- PLN 36.61T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Kymera TherapeuticsKYMR · Health Care | PLN 6.4B | PLN 41.6B | PLN 487.56 | 0.32% down | 87% up | ||
| 102 | LifeStance Health GroupLFST · Health Care | PLN 6.1B | PLN 21.1B | PLN 55.43 | 2.82% down | 129% up | ||
| 103 | InsuletPODD · Health Care | PLN 6.1B | PLN 39.1B | PLN 563.43 | 3.69% down | 58% down | ||
| 104 | CencoraCOR · Health Care | PLN 6.1B | PLN 267.5B | PLN 1,401.98 | 0.64% down | 3% down | ||
| 105 | PenumbraPEN · Health Care | PLN 5.7B | PLN 50.9B | PLN 1,290.45 | 0.47% up | 13% up | ||
| 106 | MSA SafetyMSA · Health Care | PLN 5.5B | PLN 27.5B | PLN 714.25 | 2.67% up | 11% up | ||
| 107 | Option Care HealthOPCH · Health Care | PLN 5.3B | PLN 19.1B | PLN 127.64 | 0.25% up | 14% up | ||
| 108 | Krystal BiotechKRYS · Health Care | PLN 4.9B | PLN 37.6B | PLN 1,269.28 | 5.62% up | 46% up | ||
| 109 | LivaNovaLIVN · Health Care | PLN 4.8B | PLN 21B | PLN 380.53 | 2.85% up | 71% up | ||
| 110 | RadNetRDNT · Health Care | PLN 4.4B | PLN 22.8B | PLN 289.08 | 4.14% down | 7% down | ||
| 111 | Lantheus HoldingsLNTH · Health Care | PLN 4.4B | PLN 26.9B | PLN 410.56 | 0.20% up | 93% up | ||
| 112 | Ligand PharmaceuticalsLGND · Health Care | PLN 4.1B | PLN 24.1B | PLN 1,202.34 | 1.67% up | 43% up | ||
| 113 | Legend BiotechLEGN · Health Care | PLN 4B | PLN 12.7B | PLN 65.41 | 0.87% up | 42% down | ||
| 114 | ChemedCHE · Health Care | PLN 3.9B | PLN 28.5B | PLN 2,200.60 | 0.01% down | 27% up | ||
| 115 | Oscar HealthOSCR · Health Care | PLN 3.9B | PLN 34.5B | PLN 110.97 | 7.61% down | 112% up | ||
| 116 | PACS GroupPACS · Health Care | PLN 3.8B | PLN 29.6B | PLN 186.36 | 4.63% down | 188% up | ||
| 117 | Praxis Precision MedicinesPRAX · Health Care | PLN 3.5B | PLN 34.3B | PLN 1,228.42 | 0.04% up | 61% up | ||
| 118 | ImmunovantIMVT · Health Care | PLN 3.4B | PLN 27.6B | PLN 133.51 | 0.12% down | 43% up | ||
| 119 | 10x GenomicsTXG · Health Care | PLN 3.2B | PLN 30.2B | PLN 229.71 | 1.37% up | 260% up | ||
| 120 | HaemoneticsHAE · Health Care | PLN 3.2B | PLN 22.5B | PLN 494.52 | 1.60% up | 61% up | ||
| 121 | Alnylam PharmaceuticalsALNY · Health Care | PLN 3.2B | PLN 80.5B | PLN 601.35 | 4.54% down | 66% down | ||
| 122 | Belite BioBLTE · Health Care | PLN 3.1B | PLN 25.5B | PLN 628.84 | 0.94% down | 31% up | ||
| 123 | CG OncologyCGON · Health Care | PLN 3B | PLN 28.8B | PLN 322.01 | 1.34% up | 85% up | ||
| 124 | InsmedINSM · Health Care | PLN 3B | PLN 105.8B | PLN 482.21 | 1.69% down | 40% down | ||
| 125 | Spyre TherapeuticsSYRE · Health Care | PLN 2.9B | PLN 38.8B | PLN 408.39 | 8.15% up | 286% up | ||
| 126 | Summit TherapeuticsSMMT · Health Care | PLN 2.7B | PLN 33.8B | PLN 42.26 | 1.59% down | 36% down | ||
| 127 | GlaukosGKOS · Health Care | PLN 2.6B | PLN 55.5B | PLN 938.17 | 4.18% down | 152% up | ||
| 128 | TG TherapeuticsTGTX · Health Care | PLN 2.6B | PLN 40.2B | PLN 266.14 | 5.44% up | 107% up | ||
| 129 | Corcept TherapeuticsCORT · Health Care | PLN 2.6B | PLN 29.9B | PLN 272.86 | 3.25% down | 8% down | ||
| 130 | Cogent BiosciencesCOGT · Health Care | PLN 2.6B | PLN 19.5B | PLN 111.94 | 0.14% down | 20% down | ||
| 131 | Protagonist TherapeuticsPTGX · Health Care | PLN 2.5B | PLN 33.4B | PLN 511.83 | 2.00% up | 46% up | ||
| 132 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 2.4B | PLN 37.2B | PLN 1,602.31 | 5.67% down | 24% down | ||
| 133 | Caris Life SciencesCAI · Health Care | PLN 2.3B | PLN 22.5B | PLN 78.49 | 2.21% down | 17% down | ||
| 134 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 2.3B | PLN 30.1B | PLN 382.59 | 0.06% down | 126% up | ||
| 135 | Hims & Hers HealthHIMS · Health Care | PLN 2.2B | PLN 16.1B | PLN 68.63 | 2.85% down | 51% down | ||
| 136 | Edgewise TherapeuticsEWTX · Health Care | PLN 2.1B | PLN 18.2B | PLN 166.52 | 1.59% down | 88% up | ||
| 137 | ABIVAXABVX · Health Care | PLN 2B | PLN 29.5B | PLN 337.42 | 2.11% up | 27% down | ||
| 138 | Dianthus TherapeuticsDNTH · Health Care | PLN 2B | PLN 19B | PLN 338.03 | 3.45% down | 113% up | ||
| 139 | Ionis PharmaceuticalsIONS · Health Care | PLN 2B | PLN 18.4B | PLN 110.25 | 1.59% up | 64% down | ||
| 140 | BillionToOneBLLN · Health Care | PLN 1.9B | PLN 17.6B | PLN 368.46 | 6.11% down | 0% up | ||
| 141 | Twist BioscienceTWST · Health Care | PLN 1.9B | PLN 31.9B | PLN 468.32 | 3.88% up | 340% up | ||
| 142 | Oruka TherapeuticsORKA · Health Care | PLN 1.9B | PLN 26.1B | PLN 385.36 | 0.60% down | 241% up | ||
| 143 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 1.9B | PLN 24.5B | PLN 173.52 | 0.28% up | 10% up | ||
| 144 | Medpace HoldingsMEDP · Health Care | PLN 1.8B | PLN 72.8B | PLN 2,603.72 | 0.95% down | 10% up | ||
| 145 | Concentra Group Holdings ParentCON · Health Care | PLN 1.6B | PLN 21.2B | PLN 168.97 | 0.94% down | 120% up | ||
| 146 | Definium TherapeuticsDFTX · Health Care | PLN 1.3B | PLN 16B | PLN 117.21 | 0.88% down | 169% up | ||
| 147 | ErascaERAS · Health Care | PLN 1.3B | PLN 19.4B | PLN 55.39 | 0.94% down | 403% up | ||
| 148 | Mirum PharmaceuticalsMIRM · Health Care | PLN 1.3B | PLN 24.3B | PLN 372.28 | 0.59% up | 31% up | ||
| 149 | HeartflowHTFL · Health Care | PLN 1.2B | PLN 16.2B | PLN 184.71 | 2.51% down | 73% up | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | PLN 988.1M | PLN 23.6B | PLN 193.20 | 6.48% up | 14% up | ||
| 151 | Adaptive BiotechnologiesADPT · Health Care | PLN 880.7M | PLN 18.5B | PLN 114.55 | 0.11% down | 88% up | ||
| 152 | Kodiak SciencesKOD · Health Care | PLN 633.5M | PLN 25.7B | PLN 393.70 | 1.04% up | 396% up | ||
| 153 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 559.8M | PLN 33.2B | PLN 479.15 | 2.08% up | 13% up | ||
| 154 | Travere TherapeuticsTVTX · Health Care | PLN 462.2M | PLN 19.4B | PLN 202.22 | 1.68% down | 44% up | ||
| 155 | Axsome TherapeuticsAXSM · Health Care | PLN 355.4M | PLN 28.4B | PLN 539.36 | 1.43% down | 7% down | ||
| 156 | Halozyme TherapeuticsHALO · Health Care | PLN 196.5M | PLN 44B | PLN 385.60 | 0.18% down | 37% up | ||
| 157 | Mettler-Toledo InternationalMTD · Health Care | -PLN 95.1M | PLN 139.1B | PLN 6,992.65 | 1.42% up | 22% up | ||
| 158 | Amneal PharmaceuticalsAMRX · Health Care | -PLN 285M | PLN 30.7B | PLN 88.07 | 3.60% up | 83% up | ||
| 159 | Guardant HealthGH · Health Care | -PLN 399.7M | PLN 79B | PLN 584.20 | 1.30% up | 44% up | ||
| 160 | VeradermicsMANE · Health Care | -PLN 487.1M | PLN 21.2B | PLN 502.57 | 0.62% down | 233% up | ||
| 161 | Ascendis PharmaASND · Health Care | -PLN 727.1M | PLN 71.4B | PLN 1,088.11 | 0.32% down | 28% up | ||
| 162 | PTC TherapeuticsPTCT · Health Care | -PLN 826.4M | PLN 20.3B | PLN 242.43 | 0.22% down | 20% down | ||
| 163 | ImmunityBioIBRX · Health Care | -PLN 2B | PLN 28.7B | PLN 26.97 | 7.03% up | 193% up | ||
| 164 | DaVitaDVA · Health Care | -PLN 2.6B | PLN 41B | PLN 651.22 | 6.48% down | 50% up | ||
| 165 | CytokineticsCYTK · Health Care | -PLN 2.7B | PLN 28.8B | PLN 206.57 | 0.64% down | 20% down | ||
| 166 | BridgeBio PharmaBBIO · Health Care | -PLN 8.4B | PLN 61.2B | PLN 314.00 | 1.58% up | 17% up | ||
| 167 | McKessonMCK · Health Care | -PLN 8.7B | PLN 504B | PLN 4,364.94 | 0.66% down | 28% up | ||
| 168 | Cardinal HealthCAH · Health Care | -PLN 11.6B | PLN 258.9B | PLN 1,120.27 | 0.33% down | 35% up | ||
| 169 | AbbVieABBV · Health Care | -PLN 13.2B | PLN 2.03T | PLN 1,151.22 | 2.33% down | 26% up | ||
| 170 | HCA HealthcareHCA · Health Care | -PLN 24.3B | PLN 400.5B | PLN 1,917.36 | 4.96% down | 4% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0251 PLN).
Questions and answers
Which health care companies rank first by net assets?
UnitedHealth Group (PLN 402.9B), Pfizer (PLN 348.1B) and Johnson & Johnson (PLN 328.2B) are the top three of the 170 health care companies ranked by net assets as of 19 Nov 2026, 04:24 UTC.
How many health care companies are in this ranking?
170 are ranked by net assets.
What are these health care companies worth together?
The 170 health care companies ranked by net assets have a combined market value of PLN 36.61T as of 19 Nov 2026, 04:24 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.